79 FR 6 pg. 1633 - Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Small-Molecule Antidotes to Ribosome-Inactivating Proteins
Type: NOTICEVolume: 79Number: 6Page: 1633
Page: 1633FR document: [FR Doc. 2014-00146 Filed 1-8-14; 8:45 am]
Agency: Defense Department
Sub Agency: Army Department
Official PDF Version: PDF Version
[top]
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Small-Molecule Antidotes to Ribosome-Inactivating Proteins
AGENCY:
Department of the Army, DoD.
ACTION:
Notice.
SUMMARY:
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/826,820, entitled "Small-Molecule Antidotes to Ribosome-Inactivating Proteins," filed on May 23, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
ADDRESSES:
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619-6664, both at telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION:
The invention relates to a method of treating, inhibiting, reducing, or preventing intoxication caused by a ribosome-inactivating (RIP) in a subject which comprises administering to the subject a therapeutically effective amount of at least one compound or composition according to the present invention.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-00146 Filed 1-8-14; 8:45 am]
BILLING CODE 3710-08-P